Free equity investment tool of Japanese companies

Credit Rating Analysis

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

3-D Matrix

YA-MAN

Mitsuchi

NIX

クリエートメディック

マルマン

Meiwa Industry

KAWAI MUSICAL INSTRUMENTS MANUFACTURING

UMN Pharma

Medrx

chuo kagaku co.

ＭＩＣＳ化学

ニレコ

EIDAI KAKO

FUJICOPIAN

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

NITCHITSU　

PIONEER etc.

SANKEI CHEMICAL

日本セラミック

日本セラミック

Credit Rating Analysis: UMN Pharma (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

Credit Rating (Bankruptcy Risk): UMN Pharma (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2012-12-31	-	Non rating.	¥ 108 M -	¥ -2 B -	¥ -1 B -

Financial Timeline

Date	2012-12-31  (Annual )	2013-03-31  (First quarter )	2013-06-30  (Second quarter )	2013-09-30  (Third quarter )
Credit Rating	-	-	-	-
Total Assets	¥ 14 B	¥ 19 B	¥ 21 B	¥ 21 B
Net Assets	¥ 4 B	¥ 4 B	¥ 3 B	¥ 2 B

Financial Statement Risk Analysis: UMN Pharma (Annual ) (Consolidated )

[Date: 2012-12-31]  Danger : Warning : Caution : Good

Management Risk (*Cumulative loss)
Earned Surplus etc. (¥ -783 M) is minus, so Cumulative loss , there is a possibility that the management situation is severe.

Management Risk (*Net Income & Operating Cash Flow is minus or 0 )
Net Income(¥ -1 B) & Operating Cash Flow (¥ -1 B) is minus or 0, so , there is a possibility that the management situation is very severe.

Financing Risk (*Financial Cash Flow is plus )
Operating Cash Flow (¥ -1 B) is a minus, Financial Cash Flow (¥ 12 B) is a plus. Because sale is inactive, it may depend for financing on loan from banks, capital increase, etc.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets (¥ 307 M) is Net Income (¥ -1 B) Operating Cash Flow (¥ -1 B) is a minus, Sales (¥ 108 M) more , there is a possibility of holding the non-performing asset.

Overinvestment Risk (*Intangible Assets confirmed content)
Operating Cash Flow (¥ -1 B) and Investment Cash Flow (¥ -8 B) is minus, so , there is a possibility of the overinvestment.

Credit Rating (Bankruptcy Risk): UMN Pharma (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2012-12-31	-	Non rating.	¥ 108 M -	¥ -1 B -	¥ -1 B -

Financial Timeline

Date	-  (First quarter )	-  (Second quarter )	-  (Third quarter )	2012-12-31  (Annual )
Credit Rating	-	-	-	-
Total Assets	-	-	-	¥ 5 B
Net Assets	-	-	-	¥ 5 B

Financial Statement Risk Analysis: UMN Pharma (Annual ) (Non-Consolidated )

[Date: 2012-12-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is minus or 0 )
Net Income (¥ -1 B) is minus or 0, so , there is a possibility that the management situation is severe.

Related Information: UMN Pharma (Annual )

Statement Type

Annual : UMN Pharma

First quarter : UMN Pharma

Second quarter : UMN Pharma

Third quarter : UMN Pharma

Analysis Menu

Outline : UMN Pharma

Statement : UMN Pharma

Rating : UMN Pharma

Indicator : UMN Pharma

Download : UMN Pharma

Industry Comparison Ranking

Other Products - EDIUNET Industry Rankings

Other Products - EDIUNET Credit Rating

Other Products - EDIUNET Industry Avg

Comparison with a neighboring company

Akita - EDIUNET Prefectures

Akita秋田市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/20	Kurogane Kosakusho	C→CCC	2013-11-30
1/15	MARUZEN	AA	2013-11-30 (Q3)
1/15	ミクロン精密	BB→BBB	2013-11-30 (Q1)
1/15	グラファイトデザイン	-	2013-11-30 (Q3)
1/10	TRANSACTION	AA→A	2013-11-30 (Q1)
1/10	BROCCOLI	A→AA	2013-11-30 (Q3)
12/25	ZOJIRUSHI	BBB→BB	2013-11-20
12/13	TASAKI	C	2013-10-31
12/13	YA-MAN	BB→CC	2013-10-31 (Q2)
12/13	Miroku	A	2013-10-31

EDIUNET Investment News (Other Products)

1/20 Other Products (Kurogane Kos..

1/15 Other Products (MARUZEN:AA e..

1/10 Other Products (TRANSACTION:..

12/25 Other Products (ZOJIRUSHI:BB..

12/13 Other Products (TASAKI:C etc..

12/12 Other Products (Pharma Foods..

12/11 Other Products (光彩工芸:-→A)

12/9 Other Products (ミライアル:AA)

12/6 Other Products (3-D Matrix:B..

12/3 Other Products (General Pack..

Company Information

Ticker	Market	Industry	Month	report	Rating
UMN Pharma	4585	TSE Mothers	Other Products	12	Annual	-

Related Company

ミクロン精密 (Sales ¥ 2 B)

YAMATO　 (Sales ¥ 124 M)

FUJI SEIKI (Sales ¥ 5 B)

3-D Matrix (Sales ¥ 32 M)

chuo kagaku co. (Sales ¥ 59 B)

EIDAI KAKO (Sales ¥ 5 B)

FUJICOPIAN (Sales ¥ 9 B)

ＭＩＣＳ化学 (Sales ¥ 2 B)

NIX (Sales ¥ 3 B)

UMN Pharma (Sales ¥ 108 M)

アーク (Sales ¥ 81 B)

マルマン (Sales ¥ 6 B)

Meiwa Industry (Sales ¥ 18 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .